Research Paper Volume 15, Issue 6 pp 1944—1963
Development a m6A regulators characterized by the immune cell infiltration in stomach adenocarcinoma for predicting the prognosis and immunotherapy response
Figure 7. The m6A score predicts immunotherapeutic benefits. (A–D) TCIA database-based correlations of m6A score with IPS among the PAAD patients: (A) CTLA4(−) PD1(−) (B) CTLA4(−) PD1(+) (C) CTLA4(+) PD1(−) (D) CTLA4(+) PD1(+). (E) Distribution of m6A score in different MSI groups. (F) The ratio of MSI (microsatellite instability) in STAD samples with MSS and MSI-L and MSI-H.